Jackson Creek Investment Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-70,296
| Closed | -$1.76M | – | 330 |
|
2024
Q3 | $1.76M | Buy |
70,296
+16,000
| +29% | +$400K | 0.52% | 42 |
|
2024
Q2 | $1.01M | Sell |
54,296
-88
| -0.2% | -$1.64K | 0.37% | 140 |
|
2024
Q1 | $1.07M | Buy |
+54,384
| New | +$1.07M | 0.38% | 120 |
|
2023
Q4 | – | Sell |
-65,607
| Closed | -$1.14M | – | 333 |
|
2023
Q3 | $1.14M | Sell |
65,607
-47
| -0.1% | -$817 | 0.48% | 34 |
|
2023
Q2 | $924K | Buy |
65,654
+4,055
| +7% | +$57.1K | 0.37% | 128 |
|
2023
Q1 | $663K | Sell |
61,599
-10
| -0% | -$108 | 0.28% | 199 |
|
2022
Q4 | $923K | Buy |
+61,609
| New | +$923K | 0.41% | 77 |
|
2022
Q2 | – | Sell |
-81,995
| Closed | -$815K | – | 344 |
|
2022
Q1 | $815K | Buy |
81,995
+4,926
| +6% | +$49K | 0.3% | 180 |
|
2021
Q4 | $907K | Buy |
+77,069
| New | +$907K | 0.32% | 175 |
|